Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The high-risk plaque initiative: primary prevention of atherothrombotic events in the asymptomatic population

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Peripheral Arterial Disease in Women: an Overview of Risk Factor Profile, Clinical Features, and Outcomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Non-invasive imaging for subclinical coronary atherosclerosis in patients with peripheral artery disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Peripheral artery disease (PAD) screening in the asymptomatic population: why, how, and who?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Cutdown Technique is Superior to Fascial Closure for Femoral Artery Access after Elective Endovascular Aortic Repair

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Subclinical atherosclerosis in patients with cyanotic congenital heart disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Significance of Partial or Complete Thrombosis of the Common and Deep Femoral Vein in Patients With Deep Vein Thrombosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Elevated Renal Oxygen Extraction During Open Abdominal Aortic Aneurysm Repair Is Related to Postoperative Renal Dysfunction

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
The High-Risk Plaque (HRP) Initiative is a research and development effort to advance the understanding, recognition, and management of asymptomatic individuals at risk for a near-term atherothrombotic event such as myocardial infarction or stroke. Clinical studies using the newest technologies have been initiated, including the BioImage Study in which novel approaches are tested in a typical health plan population. Asymptomatic at-risk individuals were enrolled, including a survey-only group (n = 865), a group undergoing traditional risk factor scoring (n = 718), and a group in which all were assessed for both risk factors and subclinical atherosclerosis (n = 6104). The latter two groups underwent baseline examination in a dedicated mobile facility equipped with advanced imaging tools suitable for noninvasive screening for subclinical atherosclerosis (coronary artery calcium by computed tomography [CT], carotid and aortic disease by ultrasound, and ankle-brachial index). Selected participants were offered advanced imaging (contrast-enhanced CT, magnetic resonance imaging, and positron emission tomography/CT). Plasma, PAXgene RNA, and DNA samples were obtained for biomarker discovery studies. All individuals will be followed until 600 major atherothrombotic events have occurred in those undergoing imaging.
Original languageEnglish
JournalCurrent Atherosclerosis Reports
Volume13
Issue number5
Pages (from-to)359-66
Number of pages8
ISSN1523-3804
DOIs
Publication statusPublished - 2011

ID: 33198341